05.04.2023 - VAN BUREN TOWNSHIP, Mich., April 05, 2023 (GLOBE NEWSWIRE) - Visteon Corporation (Nasdaq: VC), a global technology company serving the mobility industry, will release its first quarter 2023 financial results before the market opens on Thursday, .
PARIS & CAMBRIDGE, Mass. (BUSINESS WIRE) Regulatory News:NANOBIOTIX (Euronext: NANO – NASDAQ: NBTX – the ‘‘Company’’), a late-stage clinical biotechnology company pioneering physics-based approaches to expand treatment possibilities for patients with cancer, today announced that it will report its financial result.
Investegate |AB Ignitis grupė Announcements | AB Ignitis grupė : Interim report for the first half-year 2021 investegate.co.uk - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from investegate.co.uk Daily Mail and Mail on Sunday newspapers.
·
Guildford, UK – 14 December 2020: Ergomed plc (LSE: ERGO) ( Ergomed or the Company ), a company focused on providing specialised services to the pharmaceutical industry, today announces the acquisition of MS Clinical Services, LLC (“MedSource”), a specialised clinical research organisation (CRO) based in Houston, Texas, USA.
Dr Miroslav Reljanović, Executive Chairman of Ergomed, said:
“We are delighted to have delivered on our strategic goals in 2020 with the expansion of our US footprint in both the CRO and PV businesses. The addition of MedSource and its complementary expertise in oncology and rare disease will further establish Ergomed as a specialised services provider in the strategically important US market, building on the successful acquisition and integration of Ashfield Pharmacovigilance (now PrimeVigilance USA) earlier this year. We look forward to developing the potential of this new business to offer truly global clinical research s